Drug-Quality System and GMPs Are Topics of Workshops

Published Online: Tuesday, June 1, 2004

In conjunction with the FDA, the Consumer Healthcare Products Association will hold summer workshops on the FDA's systems approach to drug quality. Attendees will have an opportunity to interact with FDA personnel and to work in a collaborative manner to create new ways to guarantee product quality across a variety of disciplines and organizations.

Because the current drug-quality system of regulating, complying, and implementing is under review, the FDA has affirmed that a risk- and science-based approach is its preferred path for the future. The new current Good Manufacturing Practices will include potential program-management and logistical benefits for both the FDA and the pharmaceutical industry, with the goal of accommodating continued improvements while allowing for the use of new technologies and management practices.

Workshops will be held in Parsippany, NJ, on July 12, 2004, and in Chicago, Ill, on August 9, 2004. For more information, visit www.chpa-info.org.

Latest Articles
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Latest Issues